A longitudinal study on resting state functional connectivity in behavioral variant frontotemporal dementia and Alzheimer’s disease

Manuscript Number: 

15-0695R2

Author(s): 
Frederik Barkhof, Elise G.P. Dopper, Anne Hafkemeijer, Lize C. Jiskoot, Christiane Möller, Yolande A.L. Pijnenburg, Serge A.R.B. Rombouts, Philip Scheltens, Hugo Vrenken, John C. van Swieten, Annette A. van den Berg-Huysmans, Wiesje M. van der Flier, Jeroen van der Grond

Disclosures

Frederik Barkhof

  • Consulting Fees:
    Served on the advisory boards of: Bayer-Schering Pharma, Sanofi-Aventis, Biogen Idec, UCB, Merck-Serono, Novaritis, and Roche. For this activities he receives no personal compensation.
    Lecture Fees:
    Has been a speaker at symposia organized by the Serono Symposia Foundation.

Elise G.P. Dopper

  • Nothing to Disclose

Anne Hafkemeijer

  • Nothing to Disclose

Lize C. Jiskoot

  • Nothing to Disclose

Christiane Möller

  • Nothing to Disclose

Yolande A.L. Pijnenburg

  • Nothing to Disclose

Serge A.R.B. Rombouts

  • Nothing to Disclose

Philip Scheltens

  • Consulting Fees:
    Served on the advisory boards of: Genentech, Novaritis, Roche, Danone, Nutricia, Baxter and Lundbeck and on the editorial board of Alzheimer’s Research & Therapy and Alzheimer’s Disease and Associated Disorders. Member of the scientific advisory board of the EU Joint Programming Initiative and the French National Plan Alzheimer. For all this activities he receives no personal compensation.
    Lecture Fees:
    Has been a speaker at symposia organized by Lundbeck, Merz, Danone, Novartis, Roche and Genentech.

Annette A. van den Berg-Huysmans

  • Nothing to Disclose

Wiesje M. van der Flier

  • Lecture Fees:
    Received speaker honoraria from Boehringer Ingelheim. All funds were paid to the institution.
    Grants
    • Agency: 
      Boehringer Ingelheim
    • Agency: 
      Piramal Imaging
    • Agency: 
      Roche BV
    • Agency: 
      Janssen-Stellar

Jeroen van der Grond

  • Nothing to Disclose

John C. van Swieten

  • Nothing to Disclose

Hugo Vrenken

  • Lecture Fees:
    Received speaker honoraria from Novartis. All funds were paid to the institution.
    Grants
    • Agency: 
      Merck-Serono
    • Agency: 
      Novartis
    • Agency: 
      Pfizer